Renovaro Biosciences (RENB) Q3 2021 Earnings

15NovExpected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-0.36
-0.26
-0.16
-0.06

Details

Expected EPS
N/A
Actual EPS
-0.2
Surprise EPS
-0.2
Surprise Percent
+∞%

Description

Renovaro Biosciences (RENB) has reported earnings of -0.2 per share for Q3 2021.

0 Comments

Share your thoughts